Table 8.6b

Immunosuppression Use for Induction by Discharge Regimen, 2002 to 2006

Recipients with Kidney-Pancreas Transplants

  Discharge Regimen (w/ or w/o Steroids Use) All
CyA Tac CyA+ MMF Tac+ MMF CyA+ Aza Tac+ Aza Siro+ MMF CyA+ Siro Tac+ Siro Other
Functioning Graft with Immunosuppression Info at Discharge 2 175 157 3,061 1 20 83 127 362 332 4,320
% of All Regimens 0.0% 4.1% 3.6% 70.9% 0.0% 0.5% 1.9% 2.9% 8.4% 7.7% 100.0%
Induction Drug 0.0% 1.1% 0.6% 2.5% 0.0% 0.0% 1.2% 0.0% 0.3% 2.4% 2.1%
Atgam/NRATG/NRATS
OKT3 0.0% 1.1% 0.0% 0.7% 0.0% 0.0% 2.4% 0.0% 1.1% 1.5% 0.8%
Thymoglobulin 100.0% 33.7% 42.7% 48.3% 0.0% 40.0% 16.9% 83.5% 48.3% 75.6% 50.0%
Zenapax 0.0% 5.1% 7.6% 8.7% 0.0% 10.0% 1.2% 1.6% 6.9% 8.4% 8.0%
Simulect 0.0% 4.0% 41.4% 15.0% 0.0% 35.0% 6.0% 0.8% 3.6% 13.0% 13.9%
Campath 0.0% 25.7% 0.6% 6.9% 0.0% 0.0% 68.7% 0.8% 18.0% 23.5% 10.6%
No Induction Drugs Recorded 0.0% 33.1% 11.5% 21.4% 100.0% 15.0% 8.4% 15.7% 29.0% 10.2% 20.9%


Source: OPTN/SRTR Data as of May 1, 2007.

Individual induction drug percentages will not necessarily add up to 100 percent, as patients may be prescribed more than one induction drug.

CyA: Cyclosporine; Tac: Tacrolimus; MMF: Include MMF(Mycophenolate Mofetil) and MPA(Mycophenolate Sodium); Aza: Azathioprine; Siro: Sirolimus.